✦ LIBER ✦

Risk and Benefit Class III Antiarrhythmic Drugs

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Proarrhythmia With Class III Antiarrhyth

✍ Stefan H. Hohnloser MD 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Lessons from antiarrhythmic trials invol

✍ Yee Guan Yap; A.John Camm 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Rate-dependence of antiarrhythmic and pr

✍ J. Weirich; H. Antoni 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 191 KB

Pharmacologic and Pharmacokinetic Profil

✍ Peter R Kowey MD; Roger A Marinchak MD; Seth J Rials MD; PhD; David Bharucha MD; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 114 KB

What niche will newer class III antiarrh

✍ Bramah N. Singh; Jonnalagedda S. M. Sarma 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 606 KB

Current status of class III antiarrhythm

✍ Dan M. Roden 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 699 KB